|
|
Volumn 22, Issue 1, 2001, Pages 71-72
|
|
Interaction between dopamine and adenosine A2A receptors as a basis for the treatment of Parkinson's disease
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE;
ADENOSINE A2 RECEPTOR ANTAGONIST;
ADENOSINE A2A RECEPTOR;
DOPAMINE;
LEVODOPA;
OXIDOPAMINE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
BEHAVIOR;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG TOLERANCE;
LONG TERM CARE;
MALE;
MOTOR ACTIVITY;
NONHUMAN;
PARKINSON DISEASE;
RAT;
ANIMALS;
ANTIPARKINSON AGENTS;
DENERVATION;
DOPAMINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG INTERACTIONS;
DRUG THERAPY, COMBINATION;
DRUG TOLERANCE;
LEVODOPA;
MALE;
MOTOR ACTIVITY;
NEOSTRIATUM;
NEURAL PATHWAYS;
NEUROPROTECTIVE AGENTS;
OXIDOPAMINE;
PARKINSONIAN DISORDERS;
PYRIMIDINES;
RATS;
RATS, SPRAGUE-DAWLEY;
RECEPTOR, ADENOSINE A2A;
RECEPTORS, PURINERGIC P1;
SUBSTANTIA NIGRA;
SYMPATHOLYTICS;
TRIAZOLES;
|
|
EID: 0034938492
PISSN: 15901874
EISSN: None
Source Type: Journal
DOI: 10.1007/s100720170052 Document Type: Conference Paper |
|
Times cited : (65)
|
|
References (6)
|
